Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer
NCT02132988
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
BIOLOGICAL:
OPT-822/OPT-821
Sponsor
Mackay Memorial Hospital
Collaborators
[object Object]